MedPath

Melatonin in Epilepsy: Trial of Melatonin as add on anti-seizure medication in Epilepsy patients

Phase 4
Conditions
Health Condition 1: G400- Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onsetHealth Condition 2: G402- Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizuresHealth Condition 3: G401- Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
Registration Number
CTRI/2024/08/072001
Lead Sponsor
ppula Supriya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Focal drug resistant epilepsy patients on stable treatment during previous month

2. Recent seizure attacks [ = 3 seizures per month / clusters of seizures]

Exclusion Criteria

1.Primary sleep disorders like severe OSA, narcolepsy, cataplexy

2. Major depression

3. Neuroendocrine tumors

4. Rapidly growing brain tumors

5. Uncontrolled diabetes

6. Hepatic dysfunction

7. Severe asthma

8. Infertility

9. Pregnancy and nursing women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath